[
  {
    "title": "丽珠集团(000513.SZ)：截至12月底已累计回购169.61万股A股",
    "href": "http://stock.jrj.com.cn/2023/01/03202337256511.shtml",
    "datetime": "2023-01-03 20:23:31",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟与控股股东共设合资公司 注册资本10亿元",
    "href": "http://stock.jrj.com.cn/2022/12/12173437206305.shtml",
    "datetime": "2022-12-12 17:34:08",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：12月6日首次回购32.9万股A股",
    "href": "http://stock.jrj.com.cn/2022/12/06174437192484.shtml",
    "datetime": "2022-12-06 17:44:53",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：暂未回购公司A股股份",
    "href": "http://stock.jrj.com.cn/2022/12/04164937186926.shtml",
    "datetime": "2022-12-04 16:49:12",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟与健康元在武汉市共同投设合伙企业、寻求对公司所在产业內项目进行战略投资",
    "href": "http://stock.jrj.com.cn/2022/11/28171237171342.shtml",
    "datetime": "2022-11-28 17:12:15",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：与健康元签订2023年采购关联/连交易框架协议",
    "href": "http://stock.jrj.com.cn/2022/11/07204337118434.shtml",
    "datetime": "2022-11-07 20:43:19",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：艾普拉唑微丸肠溶片获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/03182537110470.shtml",
    "datetime": "2022-11-03 18:25:22",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：暂未回购股份",
    "href": "http://stock.jrj.com.cn/2022/11/02172437107014.shtml",
    "datetime": "2022-11-02 17:24:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团2022年前三季度净利15.07亿同比增长3.72% 存款利息收入增加",
    "href": "http://stock.jrj.com.cn/2022/10/25221137083586.shtml",
    "datetime": "2022-10-25 22:11:44",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：第三季度净利4.89亿元，同比增长25.37%",
    "href": "http://stock.jrj.com.cn/2022/10/25210837083292.shtml",
    "datetime": "2022-10-25 21:08:47",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用艾普拉唑钠及艾普拉唑肠溶片获批印度尼西亚上市",
    "href": "http://stock.jrj.com.cn/2022/09/27173537025234.shtml",
    "datetime": "2022-09-27 17:35:56",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用艾普拉唑钠及艾普拉唑肠溶片获批在印尼上市",
    "href": "http://stock.jrj.com.cn/2022/09/27172837025207.shtml",
    "datetime": "2022-09-27 17:28:51",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟以4亿元-8亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/09/14191336994954.shtml",
    "datetime": "2022-09-14 19:13:02",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟斥4亿元-8亿元回购A股股份",
    "href": "http://stock.jrj.com.cn/2022/09/14174636994610.shtml",
    "datetime": "2022-09-14 17:46:35",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟以4亿元-8亿元回购股份",
    "href": "http://stock.jrj.com.cn/2022/09/14174436994538.shtml",
    "datetime": "2022-09-14 17:44:55",
    "code": "000513"
  },
  {
    "title": "格隆汇公告精选︱比亚迪8月新能源汽车销量17.5万辆；丽珠集团新冠疫苗被纳入序贯加强免疫紧急使用",
    "href": "http://stock.jrj.com.cn/2022/09/03000736970606.shtml",
    "datetime": "2022-09-03 00:07:04",
    "code": "000513"
  },
  {
    "title": "丽珠集团：重组新型冠状病毒融合蛋白疫苗被纳入序贯加强免疫紧急使用",
    "href": "http://stock.jrj.com.cn/2022/09/02184436969131.shtml",
    "datetime": "2022-09-02 18:44:50",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：重组新型冠状病毒融合蛋白疫苗被纳入序贯加强免疫紧急使用",
    "href": "http://stock.jrj.com.cn/2022/09/02184236969212.shtml",
    "datetime": "2022-09-02 18:42:55",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：中长期事业合伙人持股计划之第二期持股计划已累计购买205.7711万股A股",
    "href": "http://stock.jrj.com.cn/2022/08/12211336896703.shtml",
    "datetime": "2022-08-12 21:13:14",
    "code": "000513"
  },
  {
    "title": "丽珠集团披露2022年半年报，实现营收63.03亿元",
    "href": "http://stock.jrj.com.cn/2022/08/10150636886550.shtml",
    "datetime": "2022-08-10 15:06:47",
    "code": "000513"
  },
  {
    "title": "丽珠集团2022年上半年净利10.18亿同比下滑4.23% 诊断试剂及设备实现销售收入下降",
    "href": "http://stock.jrj.com.cn/2022/08/09203136884262.shtml",
    "datetime": "2022-08-09 20:31:31",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：单硝酸异山梨酯片通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/07/27192936847906.shtml",
    "datetime": "2022-07-27 19:29:42",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：缬沙坦胶囊通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/06/01162936697013.shtml",
    "datetime": "2022-06-01 16:29:59",
    "code": "000513"
  },
  {
    "title": "A股异动 | 丽珠集团(000513.SZ)涨6.7% 已有针对猴痘病毒相关试剂盒产品科研储备",
    "href": "http://stock.jrj.com.cn/2022/05/26132936680611.shtml",
    "datetime": "2022-05-26 13:29:39",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)拟推中长期事业合伙人持股计划之第二期持股计划",
    "href": "http://stock.jrj.com.cn/2022/05/20211236667346.shtml",
    "datetime": "2022-05-20 21:12:22",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：截至4月底本轮已累计回购H股340.44万股",
    "href": "http://stock.jrj.com.cn/2022/05/05194536571439.shtml",
    "datetime": "2022-05-05 19:45:02",
    "code": "000513"
  },
  {
    "title": "丽珠集团2022年第一季度净利5.53亿同比增长6.47% 化学制剂产品收入增长",
    "href": "http://stock.jrj.com.cn/2022/04/22095236426527.shtml",
    "datetime": "2022-04-22 09:52:19",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)一季度净利润5.53亿元 同比增长6.47%",
    "href": "http://stock.jrj.com.cn/2022/04/21164236419547.shtml",
    "datetime": "2022-04-21 16:42:25",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)附属新冠抗原检测试剂国内获批上市",
    "href": "http://stock.jrj.com.cn/2022/04/13174536325026.shtml",
    "datetime": "2022-04-13 17:45:38",
    "code": "000513"
  },
  {
    "title": "丽珠集团：丽珠试剂新冠抗原检测试剂盒（乳胶法）获批上市",
    "href": "http://stock.jrj.com.cn/2022/04/13174336324942.shtml",
    "datetime": "2022-04-13 17:43:31",
    "code": "000513"
  },
  {
    "title": "新冠疫苗何时上市？6万投资者急盼！丽珠集团透露新进展：正全力以赴推进",
    "href": "http://stock.jrj.com.cn/2022/04/12215236318036.shtml",
    "datetime": "2022-04-12 21:52:30",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：本轮已累计回购H股340.44万股",
    "href": "http://stock.jrj.com.cn/2022/04/01170836247650.shtml",
    "datetime": "2022-04-01 17:08:40",
    "code": "000513"
  },
  {
    "title": "丽珠集团2021年净利17.76亿同比增长3.54% 董事长朱保国薪酬325万",
    "href": "http://stock.jrj.com.cn/2022/03/29181036151126.shtml",
    "datetime": "2022-03-29 18:10:44",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)2021年度净利润升3.54%至17.76亿元 拟10派13元",
    "href": "http://stock.jrj.com.cn/2022/03/28194335924305.shtml",
    "datetime": "2022-03-28 19:43:24",
    "code": "000513"
  },
  {
    "title": "【龙虎榜】丽珠集团3月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/21180134856553.shtml",
    "datetime": "2022-03-21 18:01:01",
    "code": "000513"
  },
  {
    "title": "丽珠集团：子公司克拉霉素片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/14181534825222.shtml",
    "datetime": "2022-03-14 18:15:25",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：克拉霉素片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/14165934824343.shtml",
    "datetime": "2022-03-14 16:59:57",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：截至2月底本轮已累计回购H股340.44万股",
    "href": "http://stock.jrj.com.cn/2022/03/02201334513452.shtml",
    "datetime": "2022-03-02 20:13:31",
    "code": "000513"
  },
  {
    "title": "丽珠集团AH股盘中均涨超6% V-01序贯加强III期临床中期数据积极",
    "href": "http://stock.jrj.com.cn/2022/02/17093834378659.shtml",
    "datetime": "2022-02-17 09:38:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团：重组新冠病毒融合蛋白疫苗序贯加强对于Omicron有良好的保护力",
    "href": "http://stock.jrj.com.cn/2022/02/16174734370356.shtml",
    "datetime": "2022-02-16 17:47:59",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：重组新型冠状病毒融合蛋白疫苗序贯加强Ⅲ期临床试验获关键性数据",
    "href": "http://stock.jrj.com.cn/2022/02/16174434370292.shtml",
    "datetime": "2022-02-16 17:44:40",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：截至1月底已累计回购H股340.44万股",
    "href": "http://stock.jrj.com.cn/2022/02/08191234308566.shtml",
    "datetime": "2022-02-08 19:12:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：参股公司津同仁创业板IPO被中止审核",
    "href": "http://stock.jrj.com.cn/2022/02/07163834301909.shtml",
    "datetime": "2022-02-07 16:38:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)2021年度扣非净利润预增10%-20%",
    "href": "http://stock.jrj.com.cn/2022/01/14170934158126.shtml",
    "datetime": "2022-01-14 17:09:34",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：截至12月底已累计回购1.09%H股股份",
    "href": "http://stock.jrj.com.cn/2022/01/05195934126120.shtml",
    "datetime": "2022-01-05 19:59:39",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用醋酸丙氨瑞林微球获得临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/12/29184434082279.shtml",
    "datetime": "2021-12-29 18:44:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：12月6日共计回购H股265.55万股",
    "href": "http://stock.jrj.com.cn/2021/12/06180933974607.shtml",
    "datetime": "2021-12-06 18:09:57",
    "code": "000513"
  },
  {
    "title": "丽珠集团：公司重点产品注射用艾普拉唑钠继续纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03200733961607.shtml",
    "datetime": "2021-12-03 20:07:23",
    "code": "000513"
  },
  {
    "title": "健康元(600380.SH)：丽珠集团重点产品注射用艾普拉唑钠继续纳入医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03185533961127.shtml",
    "datetime": "2021-12-03 18:55:05",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用艾普拉唑钠继续纳入医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03173333960677.shtml",
    "datetime": "2021-12-03 17:33:55",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：可行权的股票期权数量为97.79万份",
    "href": "http://stock.jrj.com.cn/2021/11/10194033832747.shtml",
    "datetime": "2021-11-10 19:40:47",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：可行权的股票期权数量为529.7236万份",
    "href": "http://stock.jrj.com.cn/2021/11/10193933832741.shtml",
    "datetime": "2021-11-10 19:39:38",
    "code": "000513"
  },
  {
    "title": "丽珠集团：V-01在巴基斯坦获准开启Ⅲ期临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/26203733756911.shtml",
    "datetime": "2021-10-26 20:37:52",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：第三季度净利润降6.37%至3.9亿元",
    "href": "http://stock.jrj.com.cn/2021/10/25213833750205.shtml",
    "datetime": "2021-10-25 21:38:43",
    "code": "000513"
  },
  {
    "title": "丽珠集团2021年前三季度净利14.53亿元 同比净利增加2.19%",
    "href": "http://stock.jrj.com.cn/2021/10/25201833749392.shtml",
    "datetime": "2021-10-25 20:18:06",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：司美格鲁肽注射液临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2021/09/14191033435061.shtml",
    "datetime": "2021-09-14 19:10:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用醋酸曲普瑞林微球上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2021/09/13173033428952.shtml",
    "datetime": "2021-09-13 17:30:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：取得重组人促卵泡激素注射液临床批件",
    "href": "http://stock.jrj.com.cn/2021/09/10172733415863.shtml",
    "datetime": "2021-09-10 17:27:15",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：1-8月共收到各项政府补助约1.36亿元",
    "href": "http://stock.jrj.com.cn/2021/09/07173533399107.shtml",
    "datetime": "2021-09-07 17:35:44",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)半年度净利润10.62亿元 同比增长5.75%",
    "href": "http://stock.jrj.com.cn/2021/08/24181233311029.shtml",
    "datetime": "2021-08-24 18:12:20",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：丽珠制药厂拟4020万元自健康元取得阿立哌唑微晶项目",
    "href": "http://stock.jrj.com.cn/2021/07/29201933171025.shtml",
    "datetime": "2021-07-29 20:19:22",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：津同仁堂于创业板IPO获深交所受理",
    "href": "http://stock.jrj.com.cn/2021/06/30182633022765.shtml",
    "datetime": "2021-06-30 18:26:55",
    "code": "000513"
  },
  {
    "title": "健康元(600380.SH)：丽珠集团参股公司津同仁堂创业板IPO获受理",
    "href": "http://stock.jrj.com.cn/2021/06/30182633022766.shtml",
    "datetime": "2021-06-30 18:26:35",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：替硝唑片拟中标第五批国家组织药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/23211032985094.shtml",
    "datetime": "2021-06-23 21:10:08",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用奥美拉唑钠通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/15000232929115.shtml",
    "datetime": "2021-06-15 00:02:19",
    "code": "000513"
  },
  {
    "title": "丽珠集团：本公司业务未涉及CRO领域",
    "href": "http://stock.jrj.com.cn/2021/06/09091232897686.shtml",
    "datetime": "2021-06-09 09:12:30",
    "code": "000513"
  },
  {
    "title": "丽珠集团销售费用超过疫情前 丽珠单抗商业化尚未实现启动重组",
    "href": "http://stock.jrj.com.cn/2021/06/09073232897433.shtml",
    "datetime": "2021-06-09 07:32:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟使用不超3亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/05/31211932852535.shtml",
    "datetime": "2021-05-31 21:19:43",
    "code": "000513"
  },
  {
    "title": "丽珠集团：重组人促卵泡激素注射液、重组人源化单克隆抗体偶联毒素药物处于临床前研究阶段",
    "href": "http://stock.jrj.com.cn/2021/05/27094232827671.shtml",
    "datetime": "2021-05-27 09:42:55",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：中长期事业合伙人持股计划之第一期持股计划完成股票购买",
    "href": "http://stock.jrj.com.cn/2021/05/26202832825028.shtml",
    "datetime": "2021-05-26 20:28:40",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)2020年度A股权益分派10派12.5元 股权登记日为5月31日",
    "href": "http://stock.jrj.com.cn/2021/05/23172432798516.shtml",
    "datetime": "2021-05-23 17:24:16",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2020年年度权益分派（A股）实施 每10股派发现金红利12.5元（含税）",
    "href": "http://stock.jrj.com.cn/2021/05/23160732798451.shtml",
    "datetime": "2021-05-23 16:07:02",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：中长期事业合伙人持股计划之第一期持股计划尚未购买公司股票",
    "href": "http://stock.jrj.com.cn/2021/05/21170832793958.shtml",
    "datetime": "2021-05-21 17:08:44",
    "code": "000513"
  },
  {
    "title": "丽珠集团2021年第一季度净利增长30.12% 本期销售增长",
    "href": "http://stock.jrj.com.cn/2021/04/22095132421436.shtml",
    "datetime": "2021-04-22 09:51:05",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)一季度净利升30.12%至5.20亿元",
    "href": "http://stock.jrj.com.cn/2021/04/21170332416788.shtml",
    "datetime": "2021-04-21 17:03:33",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用重组人绒促性素获批上市",
    "href": "http://stock.jrj.com.cn/2021/04/16092132384200.shtml",
    "datetime": "2021-04-16 09:21:39",
    "code": "000513"
  },
  {
    "title": "健康元：本公司股权比例发生变化主要系丽珠集团股权激励行权导致其总股本增加所致",
    "href": "http://stock.jrj.com.cn/2021/04/07190832326693.shtml",
    "datetime": "2021-04-07 19:08:50",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用双羟萘酸曲普瑞林微球获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/04/07173832326096.shtml",
    "datetime": "2021-04-07 17:38:52",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)截至3月底已累计回购662.86万股H股",
    "href": "http://stock.jrj.com.cn/2021/04/01215132265699.shtml",
    "datetime": "2021-04-01 21:51:13",
    "code": "000513"
  },
  {
    "title": "丽珠集团诊断试剂收入近14亿成新增长点 拟收购天津同仁堂40%股权扩展中药业务",
    "href": "http://stock.jrj.com.cn/2021/03/24061732205185.shtml",
    "datetime": "2021-03-24 06:17:19",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：“重组新型冠状病毒融合蛋白疫苗”临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2021/03/23215532204291.shtml",
    "datetime": "2021-03-23 21:55:01",
    "code": "000513"
  },
  {
    "title": "丽珠集团2020年净利17.15亿增长31.63%特色原料药销售收入提升 董事长朱保国薪酬325万",
    "href": "http://stock.jrj.com.cn/2021/03/23192232203239.shtml",
    "datetime": "2021-03-23 19:22:52",
    "code": "000513"
  },
  {
    "title": "丽珠集团：目前公司H股回购仍在实施 暂无A股回购计划",
    "href": "http://stock.jrj.com.cn/2021/03/23145532201400.shtml",
    "datetime": "2021-03-23 14:55:26",
    "code": "000513"
  },
  {
    "title": "丽珠集团：截至目前 控股子公司股权架构重组事宜尚未实施完毕",
    "href": "http://stock.jrj.com.cn/2021/03/23141632201183.shtml",
    "datetime": "2021-03-23 14:16:54",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟向若干银行申请最高不超142亿元授信融资",
    "href": "http://stock.jrj.com.cn/2021/03/22222632197036.shtml",
    "datetime": "2021-03-22 22:26:38",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟以7.24亿元受让天津同仁堂40%的股份",
    "href": "http://stock.jrj.com.cn/2021/03/22222332197022.shtml",
    "datetime": "2021-03-22 22:23:06",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)2020年度净利润升31.63%至17.15亿元 拟10派12.5元",
    "href": "http://stock.jrj.com.cn/2021/03/22221232196982.shtml",
    "datetime": "2021-03-22 22:12:30",
    "code": "000513"
  },
  {
    "title": "健康元(600380.SH)：子公司丽珠集团拟7.24亿元受让天津同仁堂40%股份",
    "href": "http://stock.jrj.com.cn/2021/03/22182532195862.shtml",
    "datetime": "2021-03-22 18:25:20",
    "code": "000513"
  },
  {
    "title": "【龙虎榜】丽珠集团3月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/19180132165107.shtml",
    "datetime": "2021-03-19 18:01:04",
    "code": "000513"
  },
  {
    "title": "丽珠集团能否迎来估值抬升的机会？",
    "href": "http://stock.jrj.com.cn/2021/03/19145332163634.shtml",
    "datetime": "2021-03-19 14:53:35",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：已累计回购H股662.86万股",
    "href": "http://stock.jrj.com.cn/2021/03/01183432051589.shtml",
    "datetime": "2021-03-01 18:34:57",
    "code": "000513"
  },
  {
    "title": "丽珠集团：丽珠集团丽珠制药厂为丽珠集团旗下全资子公司 是集团主要制剂的生产及加工基地",
    "href": "http://stock.jrj.com.cn/2021/01/26171331778104.shtml",
    "datetime": "2021-01-26 17:13:43",
    "code": "000513"
  },
  {
    "title": "丽珠集团2020年预计净利16.29亿–18.24亿增长25%–40% 新冠病毒抗体检测试剂销量增长",
    "href": "http://stock.jrj.com.cn/2021/01/25204931768592.shtml",
    "datetime": "2021-01-25 20:49:31",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)1月4日回购10.19万股H股",
    "href": "http://stock.jrj.com.cn/2021/01/04203631629133.shtml",
    "datetime": "2021-01-04 20:36:24",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：延迟实施中长期事业合伙人持股计划之第一期持股计划",
    "href": "http://stock.jrj.com.cn/2020/12/30200931606592.shtml",
    "datetime": "2020-12-30 20:09:39",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：回购期限届满 累计回购2.5亿元A股股份",
    "href": "http://stock.jrj.com.cn/2020/12/28192531587937.shtml",
    "datetime": "2020-12-28 19:25:56",
    "code": "000513"
  },
  {
    "title": "[健康元]焦东榜样 美丽马村 健康元&丽珠集团百万药品为发展添彩",
    "href": "http://stock.jrj.com.cn/2020/12/16000031510958.shtml",
    "datetime": "2020-12-16 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：公司及下属附属公司近期共计收到政府补助7204.21万元",
    "href": "http://stock.jrj.com.cn/2020/12/08173031441384.shtml",
    "datetime": "2020-12-08 17:30:08",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：共计收到政府补助7204.21万元",
    "href": "http://stock.jrj.com.cn/2020/12/08171631441080.shtml",
    "datetime": "2020-12-08 17:16:42",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟对丽珠开曼下属企业实施股权架构重组",
    "href": "http://stock.jrj.com.cn/2020/12/04203231410523.shtml",
    "datetime": "2020-12-04 20:32:53",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)截至11月底已累计回购A股609.3808万股",
    "href": "http://stock.jrj.com.cn/2020/12/01201631386772.shtml",
    "datetime": "2020-12-01 20:16:13",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：丽珠新北江与焦作健康元拟共设河南省健康元生物医药研究院",
    "href": "http://stock.jrj.com.cn/2020/11/30210531378417.shtml",
    "datetime": "2020-11-30 21:05:52",
    "code": "000513"
  },
  {
    "title": "丽珠集团：丽珠单抗公司致力于辅助生殖、抗肿瘤、自身免疫疾病等治疗领域抗体药物的研发",
    "href": "http://stock.jrj.com.cn/2020/11/13143931275250.shtml",
    "datetime": "2020-11-13 14:39:40",
    "code": "000513"
  },
  {
    "title": "每经数说丨10月下半月新药研发：丽珠集团一款必备抢救药物获批上市，信达生物PD-1第三季度卖6亿",
    "href": "http://stock.jrj.com.cn/2020/11/03172931209179.shtml",
    "datetime": "2020-11-03 17:29:11",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：在第一个行权期可行权110.73万份股票期权 行权价为28.87元/A股",
    "href": "http://stock.jrj.com.cn/2020/10/23224031119547.shtml",
    "datetime": "2020-10-23 22:40:22",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：在第二个行权期可行权597.0557万份股票期权 行权价为36.16元/A股",
    "href": "http://stock.jrj.com.cn/2020/10/23223931119548.shtml",
    "datetime": "2020-10-23 22:39:25",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：拟分拆丽珠试剂至深交所创业板上市",
    "href": "http://stock.jrj.com.cn/2020/10/23223431119553.shtml",
    "datetime": "2020-10-23 22:34:16",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：注射用丹曲林钠获药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/10/23223131119554.shtml",
    "datetime": "2020-10-23 22:31:14",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)第三季度净利润升38.52%至4.17亿元",
    "href": "http://stock.jrj.com.cn/2020/10/23222431119557.shtml",
    "datetime": "2020-10-23 22:24:48",
    "code": "000513"
  },
  {
    "title": "健康元(600380.SH)：丽珠集团董事会明确丽珠试剂将于深交所创业板分拆上市等相关内容",
    "href": "http://stock.jrj.com.cn/2020/10/23200231118665.shtml",
    "datetime": "2020-10-23 20:02:39",
    "code": "000513"
  },
  {
    "title": "健康元:联交所已同意子公司丽珠集团分拆丽珠试剂上市",
    "href": "http://stock.jrj.com.cn/2020/10/17071131071822.shtml",
    "datetime": "2020-10-17 07:11:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团(000513.SZ)：分拆丽珠试剂A股上市事项获联交所批复",
    "href": "http://stock.jrj.com.cn/2020/10/16204831069572.shtml",
    "datetime": "2020-10-16 20:48:27",
    "code": "000513"
  },
  {
    "title": "丽珠集团注射用醋酸奥曲肽微球获批临床试验",
    "href": "http://stock.jrj.com.cn/2020/09/09204430713201.shtml",
    "datetime": "2020-09-09 20:44:30",
    "code": "000513"
  },
  {
    "title": "职工医保门诊费用拟纳入报销 丽珠集团上半年归母净利润增长超35% | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/26183730595568.shtml",
    "datetime": "2020-08-26 18:37:35",
    "code": "000513"
  },
  {
    "title": "丽珠集团2020年上半年净利10.05亿增长36% 原料药和中间体产品同比增长",
    "href": "http://stock.jrj.com.cn/2020/08/26151330593949.shtml",
    "datetime": "2020-08-26 15:13:30",
    "code": "000513"
  },
  {
    "title": "[健康元]丽珠集团与中科院上海有机化学研究所共建创新蛋白降解药物研究中心",
    "href": "http://stock.jrj.com.cn/2020/08/25000030632232.shtml",
    "datetime": "2020-08-25 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团拟分拆丽珠试剂A股上市 上海医药首次进入《财富》世界500强榜单 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/10185830467433.shtml",
    "datetime": "2020-08-10 18:58:05",
    "code": "000513"
  },
  {
    "title": "丽珠集团欲分拆丽珠试剂上市",
    "href": "http://stock.jrj.com.cn/2020/08/10071130462701.shtml",
    "datetime": "2020-08-10 07:11:18",
    "code": "000513"
  },
  {
    "title": "健康元：控股子公司丽珠集团拟分拆其所属子公司丽珠试剂A股上市",
    "href": "http://stock.jrj.com.cn/2020/08/09202830457151.shtml",
    "datetime": "2020-08-09 20:28:42",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟分拆所属子公司丽珠试剂A股上市 公司持有其约39.43%的股份",
    "href": "http://stock.jrj.com.cn/2020/08/09202630457147.shtml",
    "datetime": "2020-08-09 20:26:51",
    "code": "000513"
  },
  {
    "title": "主打药品列入重点监控 丽珠集团能否破局？",
    "href": "http://stock.jrj.com.cn/2020/08/06082830438809.shtml",
    "datetime": "2020-08-06 08:28:37",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15082030245662.shtml",
    "datetime": "2020-07-15 08:20:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团上半年净利同比预增30%-40%",
    "href": "http://stock.jrj.com.cn/2020/07/14224730241967.shtml",
    "datetime": "2020-07-14 22:47:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团2020年上半年预计净利9.61亿元–10.35亿元 新型冠状病毒抗体检测试剂实现新增销售",
    "href": "http://stock.jrj.com.cn/2020/07/14200830241028.shtml",
    "datetime": "2020-07-14 20:08:16",
    "code": "000513"
  },
  {
    "title": "丽珠集团持续成长：“二次创业”样本 | 聚焦国内医药生物产业重要公司",
    "href": "http://stock.jrj.com.cn/2020/07/13102430222655.shtml",
    "datetime": "2020-07-13 10:24:54",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟开展远期外汇衍生品交易业务 交易金额不超过14亿元人民币",
    "href": "http://stock.jrj.com.cn/2020/06/05114129851142.shtml",
    "datetime": "2020-06-05 11:41:40",
    "code": "000513"
  },
  {
    "title": "丽珠集团副总裁戴卫国辞职 2019年薪酬为111.98万元",
    "href": "http://stock.jrj.com.cn/2020/05/29235229799338.shtml",
    "datetime": "2020-05-29 23:52:26",
    "code": "000513"
  },
  {
    "title": "健康元：丽珠集团拟出售尼科公司19.99%股权",
    "href": "http://stock.jrj.com.cn/2020/05/26213029770661.shtml",
    "datetime": "2020-05-26 21:30:16",
    "code": "000513"
  },
  {
    "title": "丽珠集团控股附属公司获得药品临床试验通知书",
    "href": "http://stock.jrj.com.cn/2020/05/07215629612814.shtml",
    "datetime": "2020-05-07 21:56:02",
    "code": "000513"
  },
  {
    "title": "上市公司一季报曝光私募调仓动向：新进45只股票 冯柳大幅减持丽珠集团",
    "href": "http://stock.jrj.com.cn/2020/04/27074629392105.shtml",
    "datetime": "2020-04-27 07:46:03",
    "code": "000513"
  },
  {
    "title": "丽珠集团聘任徐朋为副总裁",
    "href": "http://stock.jrj.com.cn/2020/04/21180529339755.shtml",
    "datetime": "2020-04-21 18:05:09",
    "code": "000513"
  },
  {
    "title": "丽珠集团第一季度盈利3.99亿同比增长1.68% 医院非疫情相关处方下降",
    "href": "http://stock.jrj.com.cn/2020/04/21134129337852.shtml",
    "datetime": "2020-04-21 13:41:34",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠集团发布2019环境、社会及管治报告",
    "href": "http://stock.jrj.com.cn/2020/04/15000029845642.shtml",
    "datetime": "2020-04-15 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：替硝唑片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/07191729227551.shtml",
    "datetime": "2020-04-07 19:17:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟以2.5亿元-5亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2020/03/26204329120555.shtml",
    "datetime": "2020-03-26 20:43:26",
    "code": "000513"
  },
  {
    "title": "丽珠集团2019年盈利同比增逾两成",
    "href": "http://stock.jrj.com.cn/2020/03/25220029109141.shtml",
    "datetime": "2020-03-25 22:00:31",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2019年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2020/03/25213029108883.shtml",
    "datetime": "2020-03-25 21:30:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2019年净利润同比增20% 拟10派11.5元",
    "href": "http://stock.jrj.com.cn/2020/03/25193429108158.shtml",
    "datetime": "2020-03-25 19:34:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2019年净利同比增长20% 拟10派11.5元",
    "href": "http://stock.jrj.com.cn/2020/03/25192829108100.shtml",
    "datetime": "2020-03-25 19:28:16",
    "code": "000513"
  },
  {
    "title": "国家药监局再次应急审批新冠病毒检测试剂 丽珠集团产品获批",
    "href": "http://stock.jrj.com.cn/2020/03/16201929035033.shtml",
    "datetime": "2020-03-16 20:19:58",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠医药全资子公司领投江苏新元素B轮融资",
    "href": "http://stock.jrj.com.cn/2020/03/11000029845644.shtml",
    "datetime": "2020-03-11 00:00:00",
    "code": "000513"
  },
  {
    "title": "6日公司新闻聚焦：新希望投43亿建养猪项目丽珠集团拟回购股份",
    "href": "http://stock.jrj.com.cn/2020/03/06090328965221.shtml",
    "datetime": "2020-03-06 09:03:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟斥资2.5亿-5亿元回购股份",
    "href": "http://stock.jrj.com.cn/2020/03/05184428960332.shtml",
    "datetime": "2020-03-05 18:44:30",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟2.5亿元-5亿元回购股份",
    "href": "http://stock.jrj.com.cn/2020/03/05183528960306.shtml",
    "datetime": "2020-03-05 18:35:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：新药临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/02/21181828872419.shtml",
    "datetime": "2020-02-21 18:18:59",
    "code": "000513"
  },
  {
    "title": "丽珠集团：创新药物临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/02/21181128872409.shtml",
    "datetime": "2020-02-21 18:11:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团两款新药即将临床试验 几千万研发投入将获百亿市场规模",
    "href": "http://stock.jrj.com.cn/2020/02/20083128860168.shtml",
    "datetime": "2020-02-20 08:31:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团重组抗人IL-17A/F人源化单克隆抗体注射液临床试验获批",
    "href": "http://stock.jrj.com.cn/2020/02/19215728857829.shtml",
    "datetime": "2020-02-19 21:57:03",
    "code": "000513"
  },
  {
    "title": "丽珠集团新药临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2020/02/19193228857135.shtml",
    "datetime": "2020-02-19 19:32:19",
    "code": "000513"
  },
  {
    "title": "健康元、丽珠集团：新药临床试验申请获批",
    "href": "http://stock.jrj.com.cn/2020/02/19190428856726.shtml",
    "datetime": "2020-02-19 19:04:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用阿立哌唑微球临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2020/02/17184928840244.shtml",
    "datetime": "2020-02-17 18:49:43",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用阿立哌唑微球临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2020/02/17180828840096.shtml",
    "datetime": "2020-02-17 18:08:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：控股附属公司丽珠试剂产品研发取得最新进展",
    "href": "http://stock.jrj.com.cn/2020/02/13214428825797.shtml",
    "datetime": "2020-02-13 21:44:32",
    "code": "000513"
  },
  {
    "title": "丽珠集团：新型冠状病毒IgM抗体检测试剂盒进入国家应急审批通道",
    "href": "http://stock.jrj.com.cn/2020/02/13181528824543.shtml",
    "datetime": "2020-02-13 18:15:32",
    "code": "000513"
  },
  {
    "title": "丽珠集团：新型冠状病毒IgM抗体检测试剂盒（酶联免疫法）进入国家应急审批通道",
    "href": "http://stock.jrj.com.cn/2020/02/13180328824514.shtml",
    "datetime": "2020-02-13 18:03:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：新型冠状病毒IgM抗体检测试剂盒完成研发和试生产",
    "href": "http://stock.jrj.com.cn/2020/02/03211628757960.shtml",
    "datetime": "2020-02-03 21:16:37",
    "code": "000513"
  },
  {
    "title": "丽珠集团：新型冠状病毒IgM抗体检测试剂盒已完成研发和试生产",
    "href": "http://stock.jrj.com.cn/2020/02/03204328757881.shtml",
    "datetime": "2020-02-03 20:43:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：捐赠1200万元现金+药品抗击肺炎疫情 已推出多种检测试剂",
    "href": "http://stock.jrj.com.cn/2020/01/28145228739322.shtml",
    "datetime": "2020-01-28 14:52:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团预计2019年盈利12.45亿元至13.53亿元 同比增长15%至25%",
    "href": "http://stock.jrj.com.cn/2020/01/09224128652196.shtml",
    "datetime": "2020-01-09 22:41:09",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/09213028651894.shtml",
    "datetime": "2020-01-09 21:30:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用盐酸万古霉素获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/23212728574575.shtml",
    "datetime": "2019-12-23 21:27:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用盐酸万古霉素获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/12/23210128574486.shtml",
    "datetime": "2019-12-23 21:01:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：公司注射用艾普拉唑钠纳入医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28172728463925.shtml",
    "datetime": "2019-11-28 17:27:53",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用艾普拉唑钠被纳入医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28172028463870.shtml",
    "datetime": "2019-11-28 17:20:25",
    "code": "000513"
  },
  {
    "title": "午间公告集锦：丽珠集团壹丽安纳入医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28121228462463.shtml",
    "datetime": "2019-11-28 12:12:57",
    "code": "000513"
  },
  {
    "title": "午间公告：丽珠集团产品纳入医保目录；康龙化成H股挂牌交易",
    "href": "http://stock.jrj.com.cn/2019/11/28115628462593.shtml",
    "datetime": "2019-11-28 11:56:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：单抗新药临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2019/11/21194428433834.shtml",
    "datetime": "2019-11-21 19:44:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团傅道田辞去执行董事、副总裁及下属附属公司担任一切职务",
    "href": "http://stock.jrj.com.cn/2019/09/27215528193586.shtml",
    "datetime": "2019-09-27 21:55:56",
    "code": "000513"
  },
  {
    "title": "丽珠集团大幅调整股票期权激励计划预留授予激励对象名单 新增26人",
    "href": "http://stock.jrj.com.cn/2019/09/19111628152762.shtml",
    "datetime": "2019-09-19 11:16:01",
    "code": "000513"
  },
  {
    "title": "[健康元]健康元&丽珠集团被纳入标普道琼斯指数",
    "href": "http://stock.jrj.com.cn/2019/09/11000028122290.shtml",
    "datetime": "2019-09-11 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：186个产品纳入医保目录 新进1个品种",
    "href": "http://stock.jrj.com.cn/2019/08/21212428012755.shtml",
    "datetime": "2019-08-21 21:24:46",
    "code": "000513"
  },
  {
    "title": "丽珠集团186个产品纳入医保目录 新进入1个品种",
    "href": "http://stock.jrj.com.cn/2019/08/21201728012517.shtml",
    "datetime": "2019-08-21 20:17:16",
    "code": "000513"
  },
  {
    "title": "丽珠集团：186个产品纳入医保目录 新进入1个品种",
    "href": "http://stock.jrj.com.cn/2019/08/21192328012299.shtml",
    "datetime": "2019-08-21 19:23:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：与控股股东健康元签订未来三年持续关联/连交易框架协议",
    "href": "http://stock.jrj.com.cn/2019/08/20214028006562.shtml",
    "datetime": "2019-08-20 21:40:29",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠集团纳入恒生可持续发展企业基准指数",
    "href": "http://stock.jrj.com.cn/2019/08/20000029845645.shtml",
    "datetime": "2019-08-20 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团上半年盈利7.39亿元同比增长16.7%",
    "href": "http://stock.jrj.com.cn/2019/08/18201727992797.shtml",
    "datetime": "2019-08-18 20:17:33",
    "code": "000513"
  },
  {
    "title": "丽珠集团：上半年净利7.39亿元 同比增长17%",
    "href": "http://stock.jrj.com.cn/2019/08/16204227989536.shtml",
    "datetime": "2019-08-16 20:42:30",
    "code": "000513"
  },
  {
    "title": "丽珠集团：与控股股东健康元签订未来三年持续关联/连交易框架协议",
    "href": "http://stock.jrj.com.cn/2019/08/16194027989257.shtml",
    "datetime": "2019-08-16 19:40:08",
    "code": "000513"
  },
  {
    "title": "丽珠集团2019年上半年盈利7.4亿 深化市场推广",
    "href": "http://stock.jrj.com.cn/2019/08/16192427989219.shtml",
    "datetime": "2019-08-16 19:24:42",
    "code": "000513"
  },
  {
    "title": "丽珠集团：上半年净利7.39亿元 同比增17%",
    "href": "http://stock.jrj.com.cn/2019/08/16190427989163.shtml",
    "datetime": "2019-08-16 19:04:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团旗下卡迪生物拟3000万元取得羿尊医药10%股权",
    "href": "http://stock.jrj.com.cn/2019/06/04222827664127.shtml",
    "datetime": "2019-06-04 22:28:26",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟3000万元入股羿尊医药 布局细胞治疗领域",
    "href": "http://stock.jrj.com.cn/2019/06/04173127663250.shtml",
    "datetime": "2019-06-04 17:31:36",
    "code": "000513"
  },
  {
    "title": "[健康元]\"入摩\"、\"入富\"(富 时GEIS指数)相继而来 健康元&丽珠集团传利好",
    "href": "http://stock.jrj.com.cn/2019/05/31000027646340.shtml",
    "datetime": "2019-05-31 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团一季度净利3.9亿元同比增长13% 现金流量净额为4.8亿元",
    "href": "http://stock.jrj.com.cn/2019/04/28143827501683.shtml",
    "datetime": "2019-04-28 14:38:09",
    "code": "000513"
  },
  {
    "title": "丽珠集团一季度净赚3.93亿元 同比增13%",
    "href": "http://stock.jrj.com.cn/2019/04/25194027483450.shtml",
    "datetime": "2019-04-25 19:40:29",
    "code": "000513"
  },
  {
    "title": "横琴国际休闲旅游岛建设方案出炉 机构推丽珠集团等4股",
    "href": "http://stock.jrj.com.cn/2019/04/03012727310737.shtml",
    "datetime": "2019-04-03 01:27:20",
    "code": "000513"
  },
  {
    "title": "丽珠集团去年净利10.82亿元 同比下滑76% 董事长朱保国年薪9万元",
    "href": "http://stock.jrj.com.cn/2019/03/29073527263390.shtml",
    "datetime": "2019-03-29 07:35:32",
    "code": "000513"
  },
  {
    "title": "丽珠集团2018年净利下降76% 拟10转3派12元",
    "href": "http://stock.jrj.com.cn/2019/03/27202127252228.shtml",
    "datetime": "2019-03-27 20:21:23",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2018年净利同比降76% 拟10转3派12元",
    "href": "http://stock.jrj.com.cn/2019/03/27201027252181.shtml",
    "datetime": "2019-03-27 20:10:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2018年实现净利润10.8亿元，同比下降75.56%；拟10派12元转3股",
    "href": "http://stock.jrj.com.cn/2019/03/27200727252167.shtml",
    "datetime": "2019-03-27 20:07:22",
    "code": "000513"
  },
  {
    "title": "[健康元]健康元集团&丽珠集团或“入摩”",
    "href": "http://stock.jrj.com.cn/2019/03/26000027240389.shtml",
    "datetime": "2019-03-26 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：新药临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2019/03/20185127198256.shtml",
    "datetime": "2019-03-20 18:51:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用醋酸亮丙瑞林微球获批临床试验",
    "href": "http://stock.jrj.com.cn/2019/03/15192427174571.shtml",
    "datetime": "2019-03-15 19:24:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：卡那霉素注射液通过WHO的PQ认证",
    "href": "http://stock.jrj.com.cn/2019/02/14153927044076.shtml",
    "datetime": "2019-02-14 15:39:45",
    "code": "000513"
  },
  {
    "title": "丽珠集团：注射用重组人绒促性素获注册申请",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/13080027036883.shtml",
    "datetime": "2019-02-13 08:00:03",
    "code": "000513"
  },
  {
    "title": "[健康元]丽珠集团在珠海市“党建引领,二次创业”大赛摘得一等奖",
    "href": "http://stock.jrj.com.cn/2019/01/16000026914668.shtml",
    "datetime": "2019-01-16 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：关于公司限制性股票激励计划预留授予第三个解锁期股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/12/26202026807823.shtml",
    "datetime": "2018-12-26 20:20:00",
    "code": "000513"
  },
  {
    "title": "[健康元]【集团动态】 “创”出新高度 健康元及丽珠集团再度霸屏行业榜单",
    "href": "http://stock.jrj.com.cn/2018/12/18000026760989.shtml",
    "datetime": "2018-12-18 00:00:00",
    "code": "000513"
  },
  {
    "title": "[健康元]【集团动态】| 工信部2017中国医药工业百强榜出炉,丽珠集团位列第26名",
    "href": "http://stock.jrj.com.cn/2018/12/18000026760988.shtml",
    "datetime": "2018-12-18 00:00:00",
    "code": "000513"
  },
  {
    "title": "[健康元]【集团动态】| 工信部2017中国医药工业百强榜出炉,丽珠集团位列第26名",
    "href": "http://stock.jrj.com.cn/2018/12/18000030519979.shtml",
    "datetime": "2018-12-18 00:00:00",
    "code": "000513"
  },
  {
    "title": "多家公司披露芬太尼业务详情 整体影响不大",
    "href": "http://stock.jrj.com.cn/2018/12/04032425443028.shtml",
    "datetime": "2018-12-04 03:24:42",
    "code": "000513"
  },
  {
    "title": "丽珠集团回应“芬太尼”报道：相关项目已主动终止",
    "href": "http://stock.jrj.com.cn/2018/12/03195025441969.shtml",
    "datetime": "2018-12-03 19:50:39",
    "code": "000513"
  },
  {
    "title": "健康元：子公司丽珠集团已停止生产特酚伪麻片",
    "href": "http://stock.jrj.com.cn/2018/12/03193825441936.shtml",
    "datetime": "2018-12-03 19:38:12",
    "code": "000513"
  },
  {
    "title": "丽珠集团：公司及子公司今年至今共收到2.68亿元政府补助",
    "href": "http://stock.jrj.com.cn/2018/11/12174625334135.shtml",
    "datetime": "2018-11-12 17:46:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团子公司研发药获临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/11/06175225311350.shtml",
    "datetime": "2018-11-06 17:52:32",
    "code": "000513"
  },
  {
    "title": "丽珠集团：获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/11/06172325311228.shtml",
    "datetime": "2018-11-06 17:23:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团子公司发生火灾事故",
    "href": "http://stock.jrj.com.cn/2018/10/31085625284965.shtml",
    "datetime": "2018-10-31 08:56:48",
    "code": "000513"
  },
  {
    "title": "丽珠集团：子公司发生火灾事故 未造成人员伤亡",
    "href": "http://stock.jrj.com.cn/2018/10/31082125283712.shtml",
    "datetime": "2018-10-31 08:21:04",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/25174025259509.shtml",
    "datetime": "2018-10-25 17:40:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]爱心送到寿光",
    "href": "http://stock.jrj.com.cn/2018/08/28000025012379.shtml",
    "datetime": "2018-08-28 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]喜报!丽珠集团荣获第十九届中国专利优秀奖",
    "href": "http://stock.jrj.com.cn/2018/08/28000026838085.shtml",
    "datetime": "2018-08-28 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠研发再获殊荣",
    "href": "http://stock.jrj.com.cn/2018/08/28000027010605.shtml",
    "datetime": "2018-08-28 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠荣获“最美纳税人”",
    "href": "http://stock.jrj.com.cn/2018/08/24000026838086.shtml",
    "datetime": "2018-08-24 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]让湾区这片药持续为健康加油!",
    "href": "http://stock.jrj.com.cn/2018/08/24000024996404.shtml",
    "datetime": "2018-08-24 00:00:00",
    "code": "000513"
  },
  {
    "title": "机构龙虎榜:医药股获关注 4机构买丽珠集团1.09亿",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/21221724982971.shtml",
    "datetime": "2018-08-21 22:17:28",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/17214024968278.shtml",
    "datetime": "2018-08-17 21:40:02",
    "code": "000513"
  },
  {
    "title": "丽珠集团：激励重启，星辰大海再启征途",
    "href": "http://stock.jrj.com.cn/2018/07/30155224879348.shtml",
    "datetime": "2018-07-30 15:52:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：丁苯酞氯化钠注射液获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/23152424850962.shtml",
    "datetime": "2018-07-23 15:24:32",
    "code": "000513"
  },
  {
    "title": "丽珠集团获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/07/20210224844611.shtml",
    "datetime": "2018-07-20 21:02:55",
    "code": "000513"
  },
  {
    "title": "丽珠集团：发布上市公司和丽珠单抗期权方案",
    "href": "http://stock.jrj.com.cn/2018/07/18143124833059.shtml",
    "datetime": "2018-07-18 14:31:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团聘任唐阳刚为公司常务副总裁",
    "href": "http://stock.jrj.com.cn/2018/07/17194824829680.shtml",
    "datetime": "2018-07-17 19:48:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：多项业务稳健增长 维持“推荐”评级",
    "href": "http://stock.jrj.com.cn/2018/07/17104624824296.shtml",
    "datetime": "2018-07-17 10:46:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/12213024807368.shtml",
    "datetime": "2018-07-12 21:30:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠研发再获殊荣",
    "href": "http://stock.jrj.com.cn/2018/07/06000024827093.shtml",
    "datetime": "2018-07-06 00:00:00",
    "code": "000513"
  },
  {
    "title": "A轮融资引入云锋基金 丽珠单抗将拆分单独上市",
    "href": "http://stock.jrj.com.cn/2018/07/03053424758847.shtml",
    "datetime": "2018-07-03 05:34:41",
    "code": "000513"
  },
  {
    "title": "药企掀海外“寻药”潮 多元化投资成新亮点",
    "href": "http://stock.jrj.com.cn/2018/06/27023824731497.shtml",
    "datetime": "2018-06-27 02:38:19",
    "code": "000513"
  },
  {
    "title": "丽珠集团：丽珠单抗完成A轮融资",
    "href": "http://stock.jrj.com.cn/2018/06/26093524727895.shtml",
    "datetime": "2018-06-26 09:35:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团年报推10转3派20元 股权登记6月21日",
    "href": "http://stock.jrj.com.cn/2018/06/13175824676399.shtml",
    "datetime": "2018-06-13 17:58:33",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]省委党校进修班走进丽珠",
    "href": "http://stock.jrj.com.cn/2018/05/23000024578484.shtml",
    "datetime": "2018-05-23 00:00:00",
    "code": "000513"
  },
  {
    "title": "保健品业务营收持续下滑 健康元卖子增厚利润",
    "href": "http://stock.jrj.com.cn/2018/05/22051524570905.shtml",
    "datetime": "2018-05-22 05:15:48",
    "code": "000513"
  },
  {
    "title": "丽珠集团：获得美国FDA临床试验许可",
    "href": "http://stock.jrj.com.cn/2018/05/17192524555210.shtml",
    "datetime": "2018-05-17 19:25:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：参芪扶正注射液获美国FDA临床试验许可",
    "href": "http://stock.jrj.com.cn/2018/05/17190024555111.shtml",
    "datetime": "2018-05-17 19:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：已梳理旗下土地运营项目近10个 总价值累计逾百亿元",
    "href": "http://stock.jrj.com.cn/2018/05/11142024526973.shtml",
    "datetime": "2018-05-11 14:20:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团卖资产派11亿红利 产品营收毛利首次双降",
    "href": "http://stock.jrj.com.cn/2018/04/02174324339604.shtml",
    "datetime": "2018-04-02 17:43:05",
    "code": "000513"
  },
  {
    "title": "丽珠集团扣非后净利润增2成 拟10转3股派20元",
    "href": "http://stock.jrj.com.cn/2018/03/23212324288556.shtml",
    "datetime": "2018-03-23 21:23:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团年报业绩增四倍 拟10转3派20元",
    "href": "http://stock.jrj.com.cn/2018/03/23211624288530.shtml",
    "datetime": "2018-03-23 21:16:01",
    "code": "000513"
  },
  {
    "title": "丽珠集团：每股收益8.09元 拟10转3派20元",
    "href": "http://stock.jrj.com.cn/2018/03/23201524288300.shtml",
    "datetime": "2018-03-23 20:15:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：业绩将稳定增长 单抗+微球平台持续推进",
    "href": "http://stock.jrj.com.cn/hotstock/2018/02/12032224101028.shtml",
    "datetime": "2018-02-12 03:22:23",
    "code": "000513"
  },
  {
    "title": "丽珠集团:具备利润分配预案实施分配的基",
    "href": "http://stock.jrj.com.cn/2018/01/25183724007256.shtml",
    "datetime": "2018-01-25 18:37:23",
    "code": "000513"
  },
  {
    "title": "丽珠集团拟推高送转 深交所追问是否利用信披配合减持？",
    "href": "http://stock.jrj.com.cn/2018/01/25161724006163.shtml",
    "datetime": "2018-01-25 16:17:22",
    "code": "000513"
  },
  {
    "title": "丽珠集团因高派息收深交所关注函",
    "href": "http://stock.jrj.com.cn/2018/01/24203724001013.shtml",
    "datetime": "2018-01-24 20:37:08",
    "code": "000513"
  },
  {
    "title": "丽珠集团 艾普拉唑注射剂通过优先审批顺利上市 15亿+重磅炸弹基因不容小觑 强烈推荐评级",
    "href": "http://stock.jrj.com.cn/2018/01/18143823967818.shtml",
    "datetime": "2018-01-18 14:38:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]双报双批 可喜可贺",
    "href": "http://stock.jrj.com.cn/2018/01/10000024498739.shtml",
    "datetime": "2018-01-10 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]朱保国董事长 描绘丽珠新时代",
    "href": "http://stock.jrj.com.cn/2018/01/10000024498738.shtml",
    "datetime": "2018-01-10 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]【2018重磅来袭】注射用艾普拉唑钠横空出世",
    "href": "http://stock.jrj.com.cn/2018/01/10000023923193.shtml",
    "datetime": "2018-01-10 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团旗下项目获国家科学技术进步二等奖",
    "href": "http://stock.jrj.com.cn/2018/01/09223923920857.shtml",
    "datetime": "2018-01-09 22:39:47",
    "code": "000513"
  },
  {
    "title": "丽珠集团：子公司利民制药获国家科学技术进步奖二等奖",
    "href": "http://stock.jrj.com.cn/2018/01/09182523919775.shtml",
    "datetime": "2018-01-09 18:25:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团 十年磨一剑 艾普拉唑针剂即将获批 强烈推荐评级",
    "href": "http://stock.jrj.com.cn/2018/01/08160523913288.shtml",
    "datetime": "2018-01-08 16:05:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：现价激励 体现雄心壮志",
    "href": "http://stock.jrj.com.cn/hotstock/2017/12/23035723840677.shtml",
    "datetime": "2017-12-23 03:57:39",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]国家发改委副司长莅临丽珠调研",
    "href": "http://stock.jrj.com.cn/2017/11/06000026838083.shtml",
    "datetime": "2017-11-06 00:00:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]丽珠单抗公司PD-1单抗喜获美国FDA临床批件",
    "href": "http://stock.jrj.com.cn/2017/11/06000026838084.shtml",
    "datetime": "2017-11-06 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团全年预增451%-471%",
    "href": "http://stock.jrj.com.cn/2017/10/25200423284090.shtml",
    "datetime": "2017-10-25 20:04:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：前三季度净利同比增591% 受益于珠海维星实业的转让",
    "href": "http://stock.jrj.com.cn/2017/10/25192523283964.shtml",
    "datetime": "2017-10-25 19:25:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：关于非公开发行限售股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2017/09/18180023132125.shtml",
    "datetime": "2017-09-18 18:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：预计前三季净利大增 转让维星实业增利近35亿",
    "href": "http://stock.jrj.com.cn/2017/08/22211022982878.shtml",
    "datetime": "2017-08-22 21:10:00",
    "code": "000513"
  },
  {
    "title": "[丽珠集团]中国品牌日 丽珠在路上",
    "href": "http://stock.jrj.com.cn/2017/06/22000023944451.shtml",
    "datetime": "2017-06-22 00:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：筹划转让下属子公司 14日开市起停牌",
    "href": "http://stock.jrj.com.cn/2017/04/13192022313181.shtml",
    "datetime": "2017-04-13 19:20:52",
    "code": "000513"
  },
  {
    "title": "丽珠集团：2016年度业绩同比增26% 拟10转3派3",
    "href": "http://stock.jrj.com.cn/2017/03/24205722225817.shtml",
    "datetime": "2017-03-24 20:57:19",
    "code": "000513"
  },
  {
    "title": "丽珠集团申购定增价涨超32% 社保基金抢筹概念股",
    "href": "http://stock.jrj.com.cn/2016/09/20052021504436.shtml",
    "datetime": "2016-09-20 05:20:20",
    "code": "000513"
  },
  {
    "title": "健康元：控股子公司丽珠集团获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2016/06/06080021038650.shtml",
    "datetime": "2016-06-06 08:00:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团设立肿瘤基金检测合资公司",
    "href": "http://stock.jrj.com.cn/2016/02/23195120597434.shtml",
    "datetime": "2016-02-23 19:51:28",
    "code": "000513"
  },
  {
    "title": "丽珠集团拟定增14.58亿元加码医药主业",
    "href": "http://stock.jrj.com.cn/2015/11/02193520015008.shtml",
    "datetime": "2015-11-02 19:35:09",
    "code": "000513"
  },
  {
    "title": "丽珠集团拟出资联合设立产业投资基金",
    "href": "http://stock.jrj.com.cn/2015/09/24203819862153.shtml",
    "datetime": "2015-09-24 20:38:27",
    "code": "000513"
  },
  {
    "title": "医药大佬朱保国获“金字招牌” 健康元闻风涨停",
    "href": "http://stock.jrj.com.cn/2014/07/28145817689865.shtml",
    "datetime": "2014-07-28 14:58:01",
    "code": "000513"
  },
  {
    "title": "丽珠集团因泄密事件推迟股权激励",
    "href": "http://stock.jrj.com.cn/2014/06/12022117388735.shtml",
    "datetime": "2014-06-12 02:21:37",
    "code": "000513"
  },
  {
    "title": "丽珠集团股权激励计划延后",
    "href": "http://stock.jrj.com.cn/2014/06/12005217388050.shtml",
    "datetime": "2014-06-12 00:52:37",
    "code": "000513"
  },
  {
    "title": "STCN解读:“泄露门”事件发酵 丽珠集团推迟股权激励",
    "href": "http://stock.jrj.com.cn/2014/06/11223417387799.shtml",
    "datetime": "2014-06-11 22:34:00",
    "code": "000513"
  },
  {
    "title": "中信证券内幕门继续发酵 丽珠集团公告临时停牌",
    "href": "http://stock.jrj.com.cn/2014/06/08202817361799.shtml",
    "datetime": "2014-06-08 20:28:59",
    "code": "000513"
  },
  {
    "title": "丽珠集团股权激励方案遭泄密 分析师提前三天群发",
    "href": "http://stock.jrj.com.cn/2014/06/07085917359665.shtml",
    "datetime": "2014-06-07 08:59:32",
    "code": "000513"
  },
  {
    "title": "丽珠集团：拟联合控股股东向丽珠单抗公司增资2亿元",
    "href": "http://stock.jrj.com.cn/hotstock/2014/05/16075917216693.shtml",
    "datetime": "2014-05-16 07:59:47",
    "code": "000513"
  },
  {
    "title": "丽珠集团：单抗产品获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/hotstock/2014/03/06080016807085.shtml",
    "datetime": "2014-03-06 08:00:09",
    "code": "000513"
  },
  {
    "title": "丽珠集团B转H股今日挂牌上市",
    "href": "http://stock.jrj.com.cn/2014/01/16033016515692.shtml",
    "datetime": "2014-01-16 03:30:29",
    "code": "000513"
  },
  {
    "title": "多公司否认“B转H”审批被否",
    "href": "http://stock.jrj.com.cn/2013/07/17113815545144.shtml",
    "datetime": "2013-07-17 11:38:28",
    "code": "000513"
  },
  {
    "title": "丽珠集团B转H申请获香港联交所受理",
    "href": "http://stock.jrj.com.cn/2013/06/06214315379981.shtml",
    "datetime": "2013-06-06 21:43:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团:广东医改新政提供新的发展机遇",
    "href": "http://stock.jrj.com.cn/hotstock/2013/05/30112215352239.shtml",
    "datetime": "2013-05-30 11:22:04",
    "code": "000513"
  },
  {
    "title": "05.27重磅传闻利好消息汇总（独家）",
    "href": "http://stock.jrj.com.cn/hotstock/2013/05/27084215339322.shtml",
    "datetime": "2013-05-27 08:42:16",
    "code": "000513"
  },
  {
    "title": "丽珠集团向地震灾区捐300余万元药品50万现金",
    "href": "http://stock.jrj.com.cn/2013/04/24145515255342.shtml",
    "datetime": "2013-04-24 14:55:22",
    "code": "000513"
  },
  {
    "title": "丽珠集团：产品增势迅猛 维持公司“推荐”评级",
    "href": "http://stock.jrj.com.cn/hotstock/2013/02/27100415092183.shtml",
    "datetime": "2013-02-27 10:04:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团B转H方案获股东高票通过",
    "href": "http://stock.jrj.com.cn/2013/02/21004315071358.shtml",
    "datetime": "2013-02-21 00:43:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团一季度净利1.17亿 降6.78%",
    "href": "http://stock.jrj.com.cn/2012/04/20192912850284.shtml",
    "datetime": "2012-04-20 19:29:00",
    "code": "000513"
  },
  {
    "title": "丽珠B获控股股东增持",
    "href": "http://stock.jrj.com.cn/2012/02/28040112355383.shtml",
    "datetime": "2012-02-28 04:01:28",
    "code": "000513"
  },
  {
    "title": "上海医药：拟并购康丽制药 或从丽珠集团“夺食 ”",
    "href": "http://stock.jrj.com.cn/2012/02/06075412173367.shtml",
    "datetime": "2012-02-06 07:54:06",
    "code": "000513"
  },
  {
    "title": "丽珠集团：大股东增持B股",
    "href": "http://stock.jrj.com.cn/2011/11/10043711524941.shtml",
    "datetime": "2011-11-10 04:37:30",
    "code": "000513"
  },
  {
    "title": "丽珠集团：10亿元建设宁夏医药产业园",
    "href": "http://stock.jrj.com.cn/2011/05/31095210093074.shtml",
    "datetime": "2011-05-31 09:52:12",
    "code": "000513"
  },
  {
    "title": "丽珠集团拟投资10亿在宁夏建医药产业园",
    "href": "http://stock.jrj.com.cn/2011/05/30195510089114.shtml",
    "datetime": "2011-05-30 19:55:58",
    "code": "000513"
  },
  {
    "title": "国信证券：丽珠集团短期看新产品 长期看疫苗和单抗",
    "href": "http://stock.jrj.com.cn/2011/03/0317249352897.shtml",
    "datetime": "2011-03-03 17:24:00",
    "code": "000513"
  },
  {
    "title": "基金逆势增持丽珠集团等3只医药股",
    "href": "http://stock.jrj.com.cn/2011/02/2815109312558.shtml",
    "datetime": "2011-02-28 15:10:40",
    "code": "000513"
  },
  {
    "title": "医药三大佬丑闻频发 背后推手扑朔迷离",
    "href": "http://stock.jrj.com.cn/2011/02/2408279276341.shtml",
    "datetime": "2011-02-24 08:27:45",
    "code": "000513"
  },
  {
    "title": "丽珠集团：8亿元短期融资券注册获接受",
    "href": "http://stock.jrj.com.cn/2011/02/1422359187217.shtml",
    "datetime": "2011-02-14 22:35:04",
    "code": "000513"
  },
  {
    "title": "丽珠集团携手健康元1亿设生物公司",
    "href": "http://stock.jrj.com.cn/2010/05/3121147555915.shtml",
    "datetime": "2010-05-31 21:14:30",
    "code": "000513"
  },
  {
    "title": "丽珠集团去年净利增八倍",
    "href": "http://stock.jrj.com.cn/2010/03/0107417026481.shtml",
    "datetime": "2010-03-01 07:41:17",
    "code": "000513"
  },
  {
    "title": "丽珠集团：经营趋势将持续向好",
    "href": "http://stock.jrj.com.cn/2010/01/1115426784277.shtml",
    "datetime": "2010-01-11 15:42:00",
    "code": "000513"
  },
  {
    "title": "丽珠集团：经营趋势持续向好 买入评级",
    "href": "http://stock.jrj.com.cn/hotstock/2010/01/1115236784106.shtml",
    "datetime": "2010-01-11 15:23:00",
    "code": "000513"
  }
]